To Test or Not to Test?

“…Well when you're trying to compute risk factors some diseases like I -- to. It's a dominant genetic disease that you inherited you're gonna get it other diseases that much more subtle. Let's say you have 30% chance of getting a …”

“…You're listening to and nova science now podcast. I'm David -- In upcoming segment for nova science now we're taking a look inside the world of commercial genetic testing. Right now there's a handful of start up companies out …”

“…for the trial such as those with previous cardiovascular surgery or chronic aortic dissection. And ARB is a reasonable choice if the -- blockade alone is not controlling either blood pressure. Or utility patient in any region of the aorta. For patients in these categories who do not have hypertension if off label use of an ARB is considered. It should be in addition to but not substituted for -- blockade. -- jeans risk prediction and targeted prevention of breast cancer. . By Paul Farrow from the university of Cambridge United Kingdom. This article reviews the genetic susceptibility to breast cancer. . With emphasis on genome wide association studies. That have uncovered six single nuclear -- probably more systems with a strong statistical association with breast cancer. . Although the clinical use of single common low -- genes is limited. A small number of susceptibility illegals could distinguished women at high risk for breast cancer from women at low risk. Particularly in the context of population screening programs. Moreover stratified women according to genetic risk may improve …”

“…This audio summary is sponsored by ortho McNeil Janssen pharmaceutical -- Visit to open next 360 dot com for practice management podcasts sample and patient education resources and much more. …”